Galenica aims to separate by the end of 2017

23 January 2017 - Deborah Wilkes

Archived

Galenica says the planned separation of its Swiss business and international pharmaceutical operations into two independent listed companies called Galenica Santé and Vifor Pharma will be completed by "no later than the end of 2017, subject to the economic environment remaining stable".

Click tags below for more information on topics:

Galenica

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: